Cargando…
The Effect of Statin Added to Systemic Anticancer Therapy: A Meta-Analysis of Randomized, Controlled Trials
Preclinical studies have demonstrated that statins have anticancer properties and act in an additive or synergistic way when combined with anticancer therapy. We conducted this meta-analysis of randomized, controlled phase II or III trials to evaluate the effect of statins added to systemic anticanc...
Autores principales: | Jang, Hyun Joo, Kim, Hyeong Su, Kim, Jung Han, Lee, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210992/ https://www.ncbi.nlm.nih.gov/pubmed/30287761 http://dx.doi.org/10.3390/jcm7100325 |
Ejemplares similares
-
The addition of metformin to systemic anticancer therapy in advanced or metastatic cancers: a meta-analysis of randomized controlled trials
por: Kim, Hyeong Su, et al.
Publicado: (2020) -
Helicobacter pylori Eradication in Idiopathic Thrombocytopenic Purpura: A Meta-Analysis of Randomized Trials
por: Kim, Bum Jun, et al.
Publicado: (2018) -
The addition of bevacizumab in the first-line treatment for metastatic colorectal cancer: an updated meta-analysis of randomized trials
por: Jang, Hyun Joo, et al.
Publicado: (2017) -
Pathologic and prognostic impacts of FGFR2 amplification in gastric cancer: a meta-analysis and systemic review
por: Kim, Hyeong Su, et al.
Publicado: (2019) -
The role of targeted agents in the adjuvant treatment of colon cancer: a meta-analysis of randomized phase III studies and review
por: Kim, Bum Jun, et al.
Publicado: (2017)